Real-World Efficacy and Safety of Bevacizumab in the First-Line Treatment of Metastatic Cervical Cancer: A Cohort Study in the Total Population of Croatian Patients

BACKGROUND: Although today it is almost preventable, cervical cancer still represents a significant cancer burden, especially in some developing parts of the world. Since the introduction of bevacizumab in the first-line treatment of metastatic disease, improvements of the outcomes were noted. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Čerina, Dora, Matković, Višnja, Katić, Kristina, Belac Lovasić, Ingrid, Šeparović, Robert, Canjko, Ivana, Jakšić, Blanka, Petrić-Miše, Branka, Bajić, Žarko, Boban, Marijo, Vrdoljak, Eduard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363452/
https://www.ncbi.nlm.nih.gov/pubmed/34394349
http://dx.doi.org/10.1155/2021/2815623

Ejemplares similares

Ejemplares similares